# Interaction of BI 691751 With Itraconazole

> **NCT02044393** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** itraconazole
- **DRUG:** BI 691751
- **DRUG:** BI 691751

## Key facts

- **NCT ID:** NCT02044393
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02044393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02044393, "Interaction of BI 691751 With Itraconazole". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02044393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*